Pharmaceutical Technology, October 2009 Issue (PDF)

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2009
Volume 33
Issue 10

Getting the Truth Out of Dissolution Testing

External Link - article-819860.pdf

Articles in this issue
Pharmaceutical Technology, October 2009 Issue (PDF)
Looking Ahead: The Pharmaceutical-Science Industry
i1-631722-1408643445747.jpg
Statistical Solutions: Square Root of (N) + 1 Sampling Plan
Formulation and Evaluation of Famotidine Floating Matrix Tablets
Formulation and Evaluation of Famotidine Floating Matrix Tablets
Report From: India
Report From: India
The Emerging Markets of the East
The Emerging Markets of the East
i1-631717-1408643460933.jpg
New Leadership Seeks to Transform FDA
Quality by Design for Generic Drugs
Quality by Design for Generic Drugs
Getting the Truth out of Dissolution Testing
Getting the Truth out of Dissolution Testing
i4-631711-1408643485892.gif
Technical Note: The Case for Supplier Qualification
Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer
Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer
i1-631720-1408643450763.jpg
Progress Made on the Path to Biosimilars
PhRMA's Stake in Reform
Sneaky and Suspicious
i3_t-631714-1408643469954.jpg
In the Spotlight October 2009
Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

Susan Haigney
June 30th 2025
Article

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

Close up the media plate on hand medical technicians working on bacterial culture and drug resistance of pathogens in laboratory. | Image Credit: © analysis121980 - stock.adobe.com

Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics

Patrick Lavery
June 26th 2025
Article

Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

Susan Haigney
June 25th 2025
Article

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

European Pharmacopoeia Goes Digital

Susan Haigney
June 25th 2025
Article

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.